Unbound MEDLINE

Cytogenetic study of a pulmonary sclerosing hemangioma. Cancer genetics and cytogenetics [Cancer Genet Cytogenet] Journal article

 
TitleCytogenetic study of a pulmonary sclerosing hemangioma.
Author(s)Pareja MJ, Vargas MT, Sánchez A, Ibáñez J, González-Cámpora R 
InstitutionDepartment of Pathology, University Hospital Virgen Macarena, Avda. Dr. Fedriani s/n, 41009 Seville, Spain.
SourceCancer Genet Cytogenet 2009 Nov; 195(1):80-4.
AbstractPulmonary sclerosing hemangioma (PSH) is an uncommon benign tumor that presents as a solitary asymptomatic and slow-growing nodule. It occurs in both young and old persons; peak incidence is in the fifth decade. Both sexes are affected by this tumor, but women more frequently than men. On histological examination, PSH shows prominent sclerotization and vascularization of the tissue. Recent studies conclude that PSH derives from type II pneumocytes, but the potential for progression and histogenesis remains controversial. We report a case of pulmonary sclerosing hemangioma in a 61-year-old woman with a neoplastic node 1 cm in diameter. The karyotype was 46,XX,t(8;18),der(14;15),+14 in all the cells analyzed. PTEN (10q23) and IgH (14q32) probes were analyzed in interphase nuclei and paraffin-embedded tissues of tumor cells. These chromosome abnormalities could provide information about the relationship of genetic changes to the biological properties of sclerosing hemangioma tumors.
Languageeng
Pub Type(s)Journal Article
PubMed ID19837274